6Guyton AC . Hall JE.Textbook of Medical Physiology [M] . 10th Edition, W.B.Saundem Company, 2000: 890.
7Rosediani M,Azidah AK,Mafauzy M . Correlation between faztinsla lasma glucose,post p randia lglucose and glyeated haemoglobin and fructosarnine[ J ]. Med J Malaysia, 2006,61 ( 1 ) : 67-71.
1Nishikawa T,Araki E.Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications.Antioxid Redox Signal,2007;9(3):343-353.
2Ceretta LB,Reus GZ,Abelaira HM,et al.Increased oxidative stress and imbalance in antioxidant enzymes in the brains of alloxan-induced diabetic rats.Exp Diabetes Res,doi: 10.1155/2012/302682.
3Huang Y, Xu Y, Bi Y, et al. Relationship between CA 19-9 levels and glucose regulation in a middle-aged and elderly Chinese population[J].J Diabetes, 2012,4 (2) :147- 152.
4Gul K,Nas S,Ozdemir D,et al.CA19-9 level in patients with type 2 diabetes mellitus and its relation to the metabolic control and microvascular complications[J].Am J Med Sci, 2011,341 (1) :28-32.
5Esteghamati A, Hafezi-Nejad N, Zandieh A, et al.CA 19-9 is associated with poor glycemic control in diabetic patients: role of insulin resistance[J].Clin Lab,2014,60(3) :441-447.
6Murai J, Soga S, Saito H, et al. Study on the mechanism causing elevation of serum CA19-9 levels in diabetic patients [J].Endocr J, 2013,60(7) : 885 - 891.
7Kato N,Cui J,Kato M,et al.Structured self-monitoring of blood glucose reduces glycated hemoglobin in insulin-treated diabetes[J].J Diabetes Investig,2013,4(5):450-453.
8Dabrowski M.Glycated hemoglobin,diabetes treatment and cancer risk in type 2 diabetes.A case-control study[J].Ann Agric Environ Med,2013,20(1):116-121.
